American Society of Hematology

Figure 2.

$N fraction–based parameters and survival of aggressive ATL. (A) OS of 2 groups of pretreatment patients with aggressive ATL separated by an N/P ratio of 12.5 (n = 49). (B-C) OS (B) and PFS (C) of 2 groups of patients with aggressive ATL after 1 course of chemotherapy separated by an N fraction of 85% (n = 49). (D-E) OS (D) and PFS (E) of 2 groups of pretransplant patients with aggressive ATL separated by an N fraction of 40% (n = 33). All P values were calculated by log-rank test.$

N fraction–based parameters and survival of aggressive ATL. (A) OS of 2 groups of pretreatment patients with aggressive ATL separated by an N/P ratio of 12.5 (n = 49). (B-C) OS (B) and PFS (C) of 2 groups of patients with aggressive ATL after 1 course of chemotherapy separated by an N fraction of 85% (n = 49). (D-E) OS (D) and PFS (E) of 2 groups of pretransplant patients with aggressive ATL separated by an N fraction of 40% (n = 33). All P values were calculated by log-rank test.

This Feature Is Available To Subscribers Only